MARC K DREZNER, MD
Osteopathic Medicine at Junction Rd, Madison, WI

License number
Wisconsin 41959
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
451 Junction Rd, Madison, WI 53717
Phone
(608) 263-5010
(608) 265-7519 (Fax)
(608) 829-5485

Professional information

Marc K Drezner Photo 1

Marc K Drezner, Madison WI

Specialties:
Endocrinologist
Address:
451 Junction Rd, Madison, WI 53717
Education:
University of Pittsburgh, School of Medicine - Doctor of Medicine*
Duke University Hospital - Fellowship - Endocrinology*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*


Marc Drezner Photo 2

Sr Assoc Dean At University Of Wisconsin

Position:
Sr Assoc Dean at University of Wisconsin
Location:
Madison, Wisconsin Area
Industry:
Higher Education
Work:
University of Wisconsin - Sr Assoc Dean


Marc K Drezner Photo 3

Dr. Marc K Drezner, Madison WI - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
750 Highland Ave, Madison 53705
ENDOCRINOLOGY DIABETES CLINICS
451 Junction Rd STE 9902, Madison 53717
(608) 265-7700 (Phone), (608) 265-7519 (Fax)
Certifications:
Internal Medicine, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
750 Highland Ave, Madison 53705
ENDOCRINOLOGY DIABETES CLINICS
451 Junction Rd STE 9902, Madison 53717
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
University of Pittsburgh / Main Campus
Graduated: 1970
Duke University Hospital


Marc Drezner Photo 4

Methods For The Treatment Of X-Linked Hypophosphatemia And Related Disorders

US Patent:
2012012, May 17, 2012
Filed:
Oct 13, 2011
Appl. No.:
13/272809
Inventors:
Marc K. DREZNER - Madison WI, US
Baozhi Yuan - Madison WI, US
International Classification:
A61K 38/08, A61P 19/08
US Classification:
514 167, 514 218, 514 217, 514 216
Abstract:
The disclosure provides methods of treating X-linked hypophosphatemia, related bone demineralization and renal phosphate wasting disorders in a mammalian subject. The methods comprise administering to the subject an effective amount of a polyarginine peptide